Skip to main content
OpenTrials
Completed

NCT Number: NCT01133067

Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients

Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Tata Memorial Hospital

Mumbai, MS, 400012, India

About this study

Patients of cancer, after their primary treatment are subsequently called for follow up visits to assess the disease status. This has two important implications from the point of view of resource management. One, patients often have to travel long distances to report to the hospital and have to take care of other logistics such as their accommodation, local travel and food. Further often the patient travels with 1-2 attendants which adds to the logistic burden. Also, these patients of follow up also contribute to the load on existing hospital services. Many authors have speculated that follow-up visits generate anxiety about possible disease recurrence. On the other hand, many others have suggested that although there may be a transient increase in anxiety, patients are ultimately reassured by this practice. Hence, there is no firm evidence for the practice and the need for follow up in oncology care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination)
  • Patients should have completed radical /adjuvant treatment, if any
  • Patients of both SCLC and NSCLC
  • Patients with at least two telephone numbers (landline/mobile/both)
  • Patients willing to participate

Exclusion criteria

  • All patients for palliative intention
  • Patients with less than two contact telephone numbers -

Treatment and study plan

Primary outcomes

  1. Concurrence Between the Telephonic Interview and the Physician Assessment

    Time frame: 2 years

    The Prevalence and bias adjusted Kappa (PABAK) score for concurrence between telephonic and physician assessment of disease status of each patient at each follow up visit was analysed.

Secondary outcomes

  1. Cost Analysis

    Time frame: 2 years

    On average, each patient spent INR 5117.10 on travel and INR 3079.06 on lodging per follow up visit.

Sponsors and collaborators

Lead sponsor

Tata Memorial Hospital

Other Gov

Registry information

Official study title

A Prospective Study of Telephonic Contact and Subsequent Physical Follow up of Radically Treated Lung Cancer Patients

Acronym: TELE001

Important dates

Study start
2010
Primary completion
2016
Study completion
2016
First posted
May 28, 2010
Registry last updated
Aug 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.